Cargando…

CD82 suppresses CD44 alternative splicing-dependent melanoma metastasis by mediating U2AF2 ubiquitination and degradation

Melanoma is one of the most lethal forms of skin cancer due to its early metastatic spread. The variant form of CD44 (CD44v), a cell surface glycoprotein, is highly expressed on metastatic melanoma. The mechanisms of regulation of CD44 alternative splicing in melanoma and its pathogenic contribution...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Pu, Feng, Shan, Liu, Gentao, Wang, Heyong, Fu, Ailing, Zhu, Huifeng, Ren, Qiao, Wang, Bochu, Xu, Xingran, Bai, Huiyuan, Dong, Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033661/ https://www.ncbi.nlm.nih.gov/pubmed/27041584 http://dx.doi.org/10.1038/onc.2016.67

Ejemplares similares

RNA structure replaces the need for U2AF2 in splicing
por: Lin, Chien-Ling, et al.
Publicado: (2016)

Targeting of U2AF(65) to Sites of Active Splicing in the Nucleus
por: Gama-Carvalho, Margarida, et al.
Publicado: (1997)

CD44V3, an Alternatively Spliced Form of CD44, Promotes Pancreatic Cancer Progression
por: Zhu, Hanzhang, et al.
Publicado: (2022)

A splice site-sensing conformational switch in U2AF2 is modulated by U2AF1 and its recurrent myelodysplasia-associated mutation
por: Warnasooriya, Chandani, et al.
Publicado: (2020)

Wild-Type U2AF1 Antagonizes the Splicing Program Characteristic of U2AF1-Mutant Tumors and Is Required for Cell Survival
por: Fei, Dennis Liang, et al.
Publicado: (2016)

The Activation-Induced Assembly of an RNA/Protein Interactome Centered on the Splicing Factor U2AF2 Regulates Gene Expression in Human CD4 T Cells
por: Whisenant, Thomas C., et al.
Publicado: (2015)

RECURRENT MUTATIONS IN THE U2AF1 SPLICING FACTOR IN MYELODYSPLASTIC SYNDROMES
por: Graubert, Timothy A., et al.
Publicado: (2011)

HNRNPA1 promotes recognition of splice site decoys by U2AF2 in vivo
por: Howard, Jonathan M., et al.
Publicado: (2018)

Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer
por: Inoue, Kazushi, et al.
Publicado: (2015)

U2AF1 mutations alter splice site recognition in hematological malignancies
por: Ilagan, Janine O., et al.
Publicado: (2015)

Control of Pre-mRNA Splicing by the General Splicing Factors PUF60 and U2AF(65)
por: Hastings, Michelle L., et al.
Publicado: (2007)

Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma
por: Wu, Qiong, et al.
Publicado: (2015)

Two Arabidopsis Splicing Factors, U2AF65a and U2AF65b, Differentially Control Flowering Time by Modulating the Expression or Alternative Splicing of a Subset of FLC Upstream Regulators
por: Lee, Hee Tae, et al.
Publicado: (2023)

CD82 and Gangliosides Tune CD81 Membrane Behavior
por: Fernandez, Laurent, et al.
Publicado: (2021)

CD44 splice isoform switching determines breast cancer stem cell state
por: Zhang, Honghong, et al.
Publicado: (2019)

Splice site m(6)A methylation prevents binding of U2AF35 to inhibit RNA splicing
por: Mendel, Mateusz, et al.
Publicado: (2021)

Signal-Regulated Pre-mRNA Occupancy by the General Splicing Factor U2AF
por: Tisserant, Anne, et al.
Publicado: (2008)

Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons
Publicado: (1995)

Identification of U2AF(35)-dependent exons by RNA-Seq reveals a link between 3′ splice-site organization and activity of U2AF-related proteins
por: Kralovicova, Jana, et al.
Publicado: (2015)

Promoter R-Loops Recruit U2AF1 to Modulate Its Phase Separation and RNA Splicing
por: He, Xiaomei, et al.
Publicado: (2023)

Gene expression profiling of U2AF2 dependent RNA-protein interactions during CD4 + T cell activation
por: Whisenant, Thomas C
Publicado: (2016)

An Unusual U2AF2 Inhibits Splicing and Attenuates the Virulence of the Human Protozoan Parasite Entamoeba histolytica
por: González-Blanco, Gretter, et al.
Publicado: (2022)

Opposite Roles of Tra2β and SRSF9 in the v10 Exon Splicing of CD44
por: Oh, Jagyeong, et al.
Publicado: (2020)

An extended U2AF(65)–RNA-binding domain recognizes the 3′ splice site signal
por: Agrawal, Anant A., et al.
Publicado: (2016)

U2AF1 Mutations Alter Sequence Specificity of pre-mRNA Binding and Splicing
por: Okeyo-Owuor, Theresa, et al.
Publicado: (2014)

Alternative splicing of U2AF1 reveals a shared repression mechanism for duplicated exons
por: Kralovicova, Jana, et al.
Publicado: (2017)

RBM-5 modulates U2AF large subunit-dependent alternative splicing in C. elegans
por: Zhou, Chuanman, et al.
Publicado: (2018)

Elucidation of the aberrant 3′ splice site selection by cancer-associated mutations on the U2AF1
por: Yoshida, Hisashi, et al.
Publicado: (2020)

U2AF65-Dependent SF3B1 Function in SMN Alternative Splicing
por: Choi, Namjeong, et al.
Publicado: (2020)

The Biological and Clinical Consequences of RNA Splicing Factor U2AF1 Mutation in Myeloid Malignancies
por: Zhao, Yangjing, et al.
Publicado: (2022)

Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer.
por: Sliutz, G., et al.
Publicado: (1995)

Identification of CD44 splice variant in Korean colorectal cancers and cell lines.
por: Suh, S. I., et al.
Publicado: (1995)

Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion
por: Gaiteiro, Cristiana, et al.
Publicado: (2022)

Stoichiometries of U2AF35, U2AF65 and U2 snRNP reveal new early spliceosome assembly pathways
por: Chen, Li, et al.
Publicado: (2017)

A novel 3′ splice site recognition by the two zinc fingers in the U2AF small subunit
por: Yoshida, Hisashi, et al.
Publicado: (2015)

The U2AF1(S34F) mutation induces lineage-specific splicing alterations in myelodysplastic syndromes
por: Yip, Bon Ham, et al.
Publicado: (2017)

The liberation of CD44
por: Cichy, Joanna, et al.
Publicado: (2003)

Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells
Publicado: (1991)

Downregulation of CD44 reduces doxorubicin resistance of CD44(+)CD24(−) breast cancer cells
por: Van Phuc, Pham, et al.
Publicado: (2011)

CD44s and CD44v6 Expression in Head and Neck Epithelia
por: Mack, Brigitte, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_n2gtap325nvedg6ssj2v2a2k9f